Navigation Links
Western Pain Society Galvanizes Coalition to Launch the Alliance for Rational Use of NSAIDs
Date:9/6/2012

LAS VEGAS, Sept. 6, 2012 /PRNewswire/ -- To coincide with PAINWeek 2012, the Western Pain Society, the largest regional society of the American Pain Society, in partnership with eight professional and patient organizations, announced today the launch of the Alliance for Rational Use of NSAIDs. The Alliance will serve as a public health coalition of professional and patient organizations, clinicians and other relevant stakeholders committed to supporting the safe and appropriate use of nonsteroidal anti-inflammatory drugs (NSAIDs).

(Logo:  http://photos.prnewswire.com/prnh/20120906/NY69248LOGO-a  )

(Photo: http://photos.prnewswire.com/prnh/20120906/NY69248-INFO-b )

The Alliance is organized under the auspices of the Western Pain Society in partnership with:

  • American Academy of Nurse Practitioners
  • American Academy of Physician Assistants
  • American Association of Colleges of Pharmacy
  • American Chronic Pain Association
  • HealthyWomen
  • National Council on Patient Information and Education
  • National Kidney Foundation

NSAIDs are one of the most commonly used medications in the United States for pain relief and reduction of fever and inflammation. NSAIDs, available by prescription and sold over-the-counter (OTC) by brand and generic names, such as ibuprofen or naproxen, are generally safe when used properly. However, as with all medications, NSAIDs are not without risks and can cause significant and even life-threatening adverse events that affect gastrointestinal (digestive system), renal (kidney) and cardiovascular (heart) health.

To guide appropriate use and lessen the risk of adverse events, the FDA and medical societies strongly recommend that all NSAIDs should be administered at the lowest effective dose for the shortest duration of time, while taking into account patient-specific risk factors and clinical needs. However, implementation of this guidance is lacking and the Alliance for Rational Use of NSAIDs aims to change that.

"Failure to comply with NSAID medical guidance is common, but taking NSAIDs inappropriately can pose major health risks for those managing pain and inflammation," said Dr. Bill McCarberg, president of the Western Pain Society and Chair of the Alliance for Rational NSAID Use. "As NSAID use continues to grow in an aging America, we hope to bridge the gap between the medical guidance and real-world use of NSAIDs."

The availability and use of OTC NSAIDs complicates adherence to guidance and impacts the safe use of NSAID products. In an observational study of osteoarthritis patients, over 90 percent of patients were at increased gastrointestinal or cardiovascular risk, but more than half of those patients were prescribed OTC NSAIDs not in accordance with current guidelines or regulatory recommendations.

"There is a desperate need for education and active communication about safe use of NSAIDs with health care professionals, as well as within the patient community," said Jennifer Wagner, executive director of the Western Pain Society. "Our hope is that the Alliance will bring this initiative to life and make a difference for patients requiring the use of NSAID therapy."

While driving appropriate use of NSAIDs is imperative to prevent greater public health concerns, the Alliance recognizes the value NSAIDs serve in the pain community. Fear of side effects should not prevent people from taking NSAIDs, since untreated pain can become a serious health issue as well. Instead, it is important to be attentive to ensure that those taking NSAIDs are taking the lowest dose for the shortest duration of time.

For more information about the Alliance for Rational Use of NSAIDs, or to become an Alliance partner, visit: www.NSAIDAlliance.com. Follow us on Twitter at @NSAIDAware,  www.twitter.com/NSAIDAware.

About the Alliance for Rational Use of NSAIDs
The Alliance for Rational Use of NSAIDs is a public health coalition dedicated to the safe and appropriate use of nonsteroidal anti-inflammatory drugs (NSAIDs). The Alliance aims to bridge the gap between guidance and clinical practice, educating health care professionals and the public at-large on the and appropriate use of NSAID therapy—maximizing benefits while reducing risks, and improving health care delivery. To learn more or to get involved, visit www.NSAIDAlliance.com.


'/>"/>
SOURCE Alliance for Rational Use of NSAIDs
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The Outlook for Medical Devices in Western Europe
2. Millennium Laboratories Angela Huskey Named Industry Pain Educator of the Year by American Society of Pain Educators
3. WuXi PharmaTech Celebrates Dr. Joseph Vaccas Induction into American Chemical Societys Medicinal Chemistry Hall of Fame
4. Elevation Pharmaceuticals Presents Positive Phase 2b Results for EP-101 in COPD Patients at the European Respiratory Society Annual Congress
5. The American Society of Interventional Pain Physicians Announces Guidelines for Responsible Prescribing of Pain-Killers for Chronic Non-Cancer Pain
6. Henry Schein Chairman and CEO Stanley M. Bergman Honored By Hispanic Dental Association, National Dental Association and Society of American Indian Dentists
7. Synergy Pharmaceuticals to Present Scientific Posters at the Upcoming Gastroenterology Society Meetings in the U.S. and Europe
8. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
9. Chimerix Announces BK Virus Data In Late-Breaking Poster Session At The 24th International Congress Of The Transplantation Society
10. The Leukemia & Lymphoma Society and Celator Pharmaceuticals Announce $5 Million Partnership to Support Phase 3 Development of CPX-351 for AML
11. European Hematology Association, American Society of Hematology, and the European Cancer Patient Coalition Issue an International Call to Action to Alleviate Drug Shortages
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016 /PRNewswire/ ... pulmonary function testing company, is now able to perform sophisticated lung ... ndd Medical Technologies , Inc. Patients are ... labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients like ... any needed testing done in the comfort of her own home. ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s ... setting the bar too high can result in disappointment, perhaps even self-loathing. However, those ... goal. , Research from PsychTests.com reveals that behind the tendency to ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... ... ... recruitment firm Slone Partners is pleased to announce the placement of Suzanne ... of North American Capital Sales at HTG Molecular . , In ... commercialization of the HTG EdgeSeq system and associated reagents in North America. , Headquartered ...
Breaking Medicine News(10 mins):